ReproCELL Incorporated Logo

ReproCELL Incorporated

Provider of stem cell technology and services for research and regenerative medicine.

4978 | T

Overview

Corporate Details

ISIN(s):
JP3974770004
LEI:
Country:
Japan
Address:
横浜市港北区新横浜3−8−11

Description

ReproCELL Incorporated is a global company providing solutions for preclinical and clinical research, with a primary focus on stem cell technology, drug discovery, and regenerative medicine. The company's portfolio includes a wide range of products such as induced pluripotent stem cells (iPSCs), differentiated cells, 3D cell culture models, and specialized reagents like RNA-based reprogramming kits that avoid genomic integration. ReproCELL also offers extensive contract research services, including human tissue assays for evaluating drug efficacy and safety. A key area of expertise is the GMP-compliant manufacturing of clinical-grade iPSCs and iPSC-derived mesenchymal stem cells (iMSCs), supporting the development of advanced cell therapies. The company's tools and services are designed to help academic and commercial scientists accelerate the translation of research into clinical applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-13 07:35
確認書
Japanese ZIP 8.1 KB
2025-11-13 07:35
半期報告書-第24期(2025/04/01-2026/03/31)
Japanese ZIP 219.0 KB
2025-06-26 02:41
内部統制報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 23.4 KB
2025-06-26 02:41
確認書
Japanese ZIP 8.1 KB
2025-06-26 02:40
有価証券報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 1.1 MB
2024-11-13 07:31
確認書
Japanese ZIP 8.1 KB
2024-11-13 07:31
半期報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 221.1 KB
2024-06-26 03:02
臨時報告書
Japanese ZIP 28.0 KB
2024-06-25 07:31
内部統制報告書-第22期(2023/04/01-2024/03/31)
Japanese ZIP 22.2 KB
2024-06-25 07:30
確認書
Japanese ZIP 8.2 KB
2024-06-25 07:29
有価証券報告書-第22期(2023/04/01-2024/03/31)
Japanese ZIP 1.2 MB
2024-05-23 08:02
臨時報告書
Japanese ZIP 20.0 KB
2024-02-09 07:24
確認書
Japanese ZIP 8.2 KB
2024-02-09 07:23
四半期報告書-第22期第3四半期(2023/10/01-2023/12/31)
Japanese ZIP 227.6 KB
2023-11-10 07:05
四半期報告書-第22期第2四半期(2023/07/01-2023/09/30)
Japanese ZIP 213.2 KB

Automate Your Workflow. Get a real-time feed of all ReproCELL Incorporated filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ReproCELL Incorporated

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ReproCELL Incorporated via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DG INNOVATE PLC Logo
Develops sustainable technologies for electric mobility and energy storage solutions.
United Kingdom
DGI
Dianthus Therapeutics, Inc. /DE/ Logo
Clinical-stage biotech developing therapies for severe autoimmune diseases.
United States of America
DNTH
Dogwood Therapeutics, Inc. Logo
A biotech company developing novel therapeutics for pain and neuropathy.
United States of America
DWTX
DreamCIS INC. Logo
Contract research organization for pharma, biotech, and medical device industries.
South Korea
223250
DT&CRO CO., Ltd. Logo
A full-service CRO providing non-clinical and clinical studies for various industries.
South Korea
383930
D.Western Therapeutics Institute, Inc. Logo
Biotechnology firm developing drugs from a proprietary protein kinase inhibitor library.
Japan
4576
Ectin Research AB Logo
Pharmaceutical company developing novel oncology treatments, with a lead drug in trials.
Sweden
ECTIN B
EdgeLab S.p.A. Logo
Designs and manufactures marine and underwater solutions, including AUVs and robotics.
Italy
ELB
Editas Medicine, Inc. Logo
A clinical-stage genome editing company developing CRISPR medicines for serious diseases.
United States of America
EDIT
Eledon Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing therapies for organ and autoimmune diseases.
United States of America
ELDN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.